Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American College of Rheumatology
Payers
Pharma industry rips 'draconian' price negotiation provision
Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs said the new trend is damaging and will stunt innovation.
Noah Tong
Aug 30, 2023 12:01am
Industry Voices—E/M services have been undervalued by CMS
Sep 17, 2019 3:50pm
370 organizations urge Congress to reform MA prior authorization
Sep 11, 2019 4:02pm
Groups urge CMS to implement step therapy safeguards—Roundup
Apr 9, 2019 12:44pm
Payers, providers clash on CMS' plans for step therapy in Part B
Jan 29, 2019 7:16am
Physician groups hope to work with CMS on E/M implementation
Nov 6, 2018 8:26am
